Cargando…

P21-activated kinase 5 potentiates the chemoresistant phenotype of liver cancer

Detalles Bibliográficos
Autores principales:	Zhang, Ding-Guo, Gong, Chan-Chan, Wu, Xiao-Jin, Ren, Xin, Sedaka, Randee S., Chen, Wei-Cong, Huo, Fu-Chun, Chen, Cheng, Du, Wen-Qi, Pei, Dong-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862393/ https://www.ncbi.nlm.nih.gov/pubmed/33542180 http://dx.doi.org/10.1038/s41392-020-00409-y

Ejemplares similares

Uncoupling Protein 2 Increases Blood Pressure in DJ‐1 Knockout Mice
por: De Miguel, Carmen, et al.
Publicado: (2019)

Liver kinase B1 enhances chemoresistance to gemcitabine in breast cancer MDA-MB-231 cells
por: XIA, CHEN, et al.
Publicado: (2014)

Accelerated cystogenesis by dietary protein load is dependent on, but not initiated by kidney macrophages
por: Sedaka, Randee, et al.
Publicado: (2023)

P-21 Activated Kinases in Liver Disorders
por: Qiu, Xun, et al.
Publicado: (2023)

BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma
por: Gao, Wei, et al.
Publicado: (2017)

Protein kinase C inhibitors override ZEB1-induced chemoresistance in HCC
por: Sreekumar, Rahul, et al.
Publicado: (2019)

CCL21 Facilitates Chemoresistance and Cancer Stem Cell-Like Properties of Colorectal Cancer Cells through AKT/GSK-3β/Snail Signals
por: Lu, Lin-Lin, et al.
Publicado: (2016)

TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance
por: Ren, Hong, et al.
Publicado: (2016)

IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma
por: Myers, Amy L., et al.
Publicado: (2015)

Aurora Kinase A-YBX1 Synergy Fuels Aggressive Oncogenic Phenotypes and Chemoresistance in Castration-Resistant Prostate Cancer
por: Nikhil, Kumar, et al.
Publicado: (2020)

Fluid-electrolyte homeostasis requires histone deacetylase function
por: Hyndman, Kelly A., et al.
Publicado: (2020)

PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo
por: Zhang, Ying-Chun, et al.
Publicado: (2017)

Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease
por: Ngu, Siew-Fei, et al.
Publicado: (2014)

Repression of Dicer is associated with invasive phenotype and chemoresistance in ovarian cancer
por: KUANG, YAN, et al.
Publicado: (2013)

Stochastic modeling of phenotypic switching and chemoresistance in cancer cell populations
por: Kumar, Niraj, et al.
Publicado: (2019)

Impaired Liver Function Implied Shorter Progression Free Survival for EGFR Tyrosine Kinase Inhibitors
por: Zhu, Qi-Qi, et al.
Publicado: (2018)

Apigenin induces apoptosis and counteracts cisplatin-induced chemoresistance via Mcl-1 in ovarian cancer cells
por: Qi, Yuyan, et al.
Publicado: (2020)

Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance
por: Huang, Chung-Yen, et al.
Publicado: (2019)

Downregulated Salt-inducible Kinase 3 Expression Promotes Chemoresistance in Serous Ovarian Cancer via the ATP‐binding Cassette Protein ABCG2
por: Liang, Yu-Ling, et al.
Publicado: (2019)

MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide
por: Chen, Rui, et al.
Publicado: (2016)

CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma
por: Huang, Yue, et al.
Publicado: (2022)

Exosomes derived from HBV-associated liver cancer promote chemoresistance by upregulating chaperone-mediated autophagy
por: Liu, Dian-Xing, et al.
Publicado: (2019)

CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype
por: Zeng, Wenfeng, et al.
Publicado: (2022)

Manipulating the Tumor Microenvironment in Tumor Organoids Induces Phenotypic Changes and Chemoresistance
por: Dominijanni, Anthony, et al.
Publicado: (2020)

Substrate Stiffness Modulates the Growth, Phenotype, and Chemoresistance of Ovarian Cancer Cells
por: Fan, Yali, et al.
Publicado: (2021)

Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor
por: HUANG, RUI, et al.
Publicado: (2015)

Participation of CCL1 in Snail-Positive Fibroblasts in Colorectal Cancer Contribute to 5-Fluorouracil/Paclitaxel Chemoresistance
por: Li, Ziqian, et al.
Publicado: (2018)

Aurora-A promotes chemoresistance in hepatocelluar carcinoma by targeting NF-kappaB/microRNA-21/PTEN signaling pathway
por: Zhang, Kai, et al.
Publicado: (2014)

Evidence for G‐Protein–Coupled Estrogen Receptor as a Pronatriuretic Factor
por: Gohar, Eman Y., et al.
Publicado: (2020)

Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
por: Chen, Xun, et al.
Publicado: (2020)

Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype
por: Zhu, Xiaolan, et al.
Publicado: (2019)

Spotlight on the USA /
por: Falk, Randee
Publicado: (1993)

A multi-state model of chemoresistance to characterize phenotypic dynamics in breast cancer
por: Howard, Grant R., et al.
Publicado: (2018)

Phenotypic Basis for Matrix Stiffness-Dependent Chemoresistance of Breast Cancer Cells to Doxorubicin
por: Joyce, M. Hunter, et al.
Publicado: (2018)

Ubc9 expression predicts chemoresistance in breast cancer
por: Chen, Shi-Feng, et al.
Publicado: (2011)

The molecular basis of p21-activated kinase-associated neurodevelopmental disorders: From genotype to phenotype
por: Dobrigna, Manon, et al.
Publicado: (2023)

Inhibition of neuroblastoma proliferation by PF-3758309, a small-molecule inhibitor that targets p21-activated kinase 4
por: Li, Zhiheng, et al.
Publicado: (2017)

Inhibition of Bruton’s tyrosine kinase as a therapeutic strategy for chemoresistant oral squamous cell carcinoma and potential suppression of cancer stemness
por: Liu, Shao-Cheng, et al.
Publicado: (2021)

Nicotine-induced miR-21-3p promotes chemoresistance in lung cancer by negatively regulating FOXO3a
por: Zhang, Yong-Qing, et al.
Publicado: (2022)

MORC2, a novel oncogene, is upregulated in liver cancer and contributes to proliferation, metastasis and chemoresistance
por: Pan, Zhihong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r91jv9090cv22brgkk124n4t1h